You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Government contractor FedCentric has previously built high-performance data analytics software for the US Postal Service to improve logistics.
The agreement to develop improved methods of isolating nucleic acids from tumor samples is expected to yield new commercial products for Biomatrica and provide the company with a foothold in the molecular diagnostics market.
SAIC-Frederick and Biomatrica are collaborating on developing better processes for isolating nucleic acids from tumor samples collected by pathologists in clinics.
Under its subcontract with SAIC-Frederick, GNS will use its REFS platform to assess NCI data on several oncology drugs.
SAIC-Frederick is seeking a subcontractor to run a Comprehensive Data Resource to support the biorepository and biospecimen research programs.
The partners will use Complete Genomics' sequencing and bioinformatics services to analyze 50 tumor-normal pairs.
The collaboration is part of NCI's Advanced Technology Partnerships Initiative, which "seeks to reduce the time and cost of developing new cancer treatments," according to a statement
Under a collaboration, the two firms will integrate Geospiza software with Pacific Biosciences' PacBio RS platform.
Under the partnership, SAIC-Frederick researchers at the Core Genotyping Facility will use the Fluidigm Access Array system to target and amplify the genome of EBV DNA virus.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.